Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

JN Liao, YH Chan, L Kuo, CT Tsai… - Polish Heart Journal …, 2022 - journals.viamedica.pl
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …

[PDF][PDF] Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

JN Liao, YH Chan, L Kuo, CT Tsai, SS Lim, TF Chao - 2022 - scholar.archive.org
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …

Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

N Liao, YH Chan, L Kuo, CT Tsai… - Polish Heart Journal …, 2022 - search.ebscohost.com
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …

Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

JN Liao, YH Chan, L Kuo, CT Tsai… - Kardiologia …, 2022 - pubmed.ncbi.nlm.nih.gov
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …

Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

JN Liao, YH Chan, L Kuo, CT Tsai… - … Polska (Polish Heart …, 2022 - journals.viamedica.pl
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …

Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

JN Liao, YH Chan, L Kuo, CT Tsai, SS Lim… - Kardiologia …, 2022 - europepmc.org
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …

Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

JN Liao, YH Chan, L Kuo, CT Tsai… - Polish Heart Journal …, 2022 - search.ebscohost.com
Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …